Reimbursement of anti-obesity treatments, a complex equation for Health Insurance
⚡ Quick Summary
Reimbursed in France from Monday June 15, the anti-obesity drugs Wegovy and Mounjaro confront health administrations with a thorny question: will financing them cost less than assuming the cost of obesity and its complications?
🗞️ 1 sources covered this story
📰 Related Articles
From “Gears of War E-Day” to “Resident Evil: Veronica”: eight games to watch closely in the coming months
BFM TV
Collapse of a building in Saint-Louis: A fourth victim found under the rubble
Senego
New recall of infant milk sold in pharmacies causing diarrhea and vomiting in babies
Doctissimo
“Kaolack is dying”: Alert from Serigne Aliou Cissé Niass* on the situation in the city
Senego
Jaida and Chari want to open credit to small merchants via digital
Médias24